Status:
UNKNOWN
Tongji-Ezhou Study
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Diabetes
Cardiovascular Diseases
Eligibility:
All Genders
20-80 years
Brief Summary
Tongji-Ezhou study (TJEZ) is a prospective cohort study launched at 2013 in EZhou city, Hubei province, with the goal of recruiting and assessing 10,000 individuals and then following them for at leas...
Eligibility Criteria
Inclusion
- (i) permanent residence in Ezhou district (minimum of 9 months); (ii) written informed consent; (iii) age ≥ 20 years old at the time of enrolling in the study.
Exclusion
- (i) with chemotherapy or radiotherapy for cancer and other severe diseases.
Key Trial Info
Start Date :
April 16 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03845868
Start Date
April 16 2013
End Date
December 31 2025
Last Update
February 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030